Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

28.76
Delayed Data
As of Jun 24
 -1.41 / -4.67%
Today’s Change
25.98
Today|||52-Week Range
42.50
-10.79%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close30.17
Today’s open29.20
Day’s range28.72 - 29.52
Volume1,333,946
Average volume (3 months)383,641
Market cap$1.5B
Dividend yield--
Data as of 4:03pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-440.62%
Earnings growth (this year)-11.60%
Earnings growth (next 5 years)+7.50%
Revenue growth (last year)+0.02%
P/E ratioNM
Price/Sales1.89
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
HYHHalyard Health Inc-1.17-3.49%
PODDInsulet Corp-0.91-3.09%
ICUIICU Medical Inc-1.64-1.52%
OMCLOmnicell Inc-0.02-0.06%
Data as of 4:01pm ET, 06/24/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.29
Annual revenue (last year)$910.5M
Annual profit (last year)-$55.6M
Net profit margin-6.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President &
Chief Executive Officer
Christopher Simon
Chief Operating Officer
Kent J. Davies
Corporate headquarters
Braintree, Massachusetts

Forecasts

Partner Offers

Search for Jobs